Source: FDA, National Drug Code (US) Revision Year: 2026
Baxdrostat is an aldosterone synthase inhibitor. The chemical name of baxdrostat is N-[(8R)-4-(1-methyl-2-oxo-1,2,3,4-tetrahydro-6-quinolinyl)-5,6,7,8-tetrahydro-8-isoquinolinyl]propanamide. The molecular formula is C22H25N3O2 and the molecular weight is 363.45 g/mol. The structural formula is:
BAXFENDY is available as a film-coated tablet for oral administration, containing 1 mg or 2 mg of baxdrostat. The inactive ingredients in BAXFENDY are croscarmellose sodium, lactose anhydrous, magnesium stearate, and microcrystalline cellulose. The film coating contains the following inactive ingredients: polyethylene glycol 3350, polyvinyl alcohol, talc, and titanium dioxide, in addition to ferric oxide red (1 mg strength tablets) or ferric oxide yellow (2 mg strength tablets).
| Dosage Forms and Strengths |
|---|
|
BAXFENDY is available as film-coated tablets:
|
| How Supplied | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BAXFENDY (baxdrostat) tablets are available in the strengths and packages listed in Table 3. Table 3. BAXFENDY Tablet Presentations:
Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850 |
| Drug | Countries | |
|---|---|---|
| BAXFENDY | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.